Efficacy, Safety And Dosage Of Afatinib In Patients With Non-Small Cell Lung Cancer After Failure Of Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-Tki)

被引：0
|
作者：
Park, C. [1 ]
Kim, T. [1 ]
Shin, H. [2 ]
Ban, H. [2 ]
Lim, J. [1 ]
Kwon, Y. [2 ]
Oh, I. [1 ]
Kim, Y. [1 ,2 ]
Lim, S. [2 ]
Kim, Y. [1 ,2 ]
机构：
[1] Chonnam Natl Univ, Hwasun Hosp, Hawsun, Jeonnam, South Korea
[2] Chonnam Natl Univ Hosp, Gwangju, South Korea
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2016年 / 193卷
关键词：
lung cancer; EGFR; afatinib;
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6676
引用
收藏
页数：1
相关论文
共 50 条
  • [1] EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR (EGFR-TKI) RELATED INTERSTITIAL LUNG DISEASE IN TAIWANESE PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Chiang, Chi-Lu
    Tsai, Chun-Ming
    Lee, Yu-Chin
    Chiu, Chao-Hua
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S592 - S592
  • [2] Efficacy, Safety and Dosage of Afatinib in Patients with NSCLC after Failure of Prior EGFR-TKI
    Kim, Young-Chul
    Choi, Hayoung
    Park, Cheol-Kyu
    Oh, In-Jae
    Yun, Ju-Sik
    Song, Sang-Yun
    Na, Kook-Joo
    Ahn, Sung-Ja
    Yoon, Mee Sun
    Choi, Yoo-Duk
    Seon, Hyun-Ju
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S647 - S647
  • [3] Clinical efficacy of Apatinib combined with Epidermal growth factor receptor- tyrosine kinase inhibitor (EGFR-TKI) in nonsmall cell lung cancer after EGFR-TKI resistance
    Tian, Ruifen
    Guo, Yi
    Zhang, Xing
    Zhang, Xia
    Song, Xia
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2024, 40 (08) : 1714 - 1718
  • [4] Rare and complex mutations of epidermal growth factor receptor (EGFR) and efficacy of tyrosine kinase inhibitor (TKI) in patients with non-small cell lung cancer (NSCLC).
    Keam, Bhumsuk
    Kim, Dong-Wan
    Park, Jin Hyun
    Lee, Jeong-Ok
    Kim, Tae Min
    Lee, Se-Hoon
    Jeon, Yoon-Kyung
    Chung, Doo Hyun
    Heo, Dae Seog
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] Disease control with a second epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) after failure of a first TKI in Asian patients with non-small cell lung cancer (NSCLC)
    Wong, A.
    Lim, S. W.
    Chin, T. M.
    Soong, R.
    Soo, R. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] Dacomitinib, a second-generation irreversible epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) to treat non-small cell lung cancer
    Nagano, T.
    Tachihara, M.
    Nishimura, Y.
    DRUGS OF TODAY, 2019, 55 (04) : 231 - 236
  • [7] Role of chemotherapy with epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) rechallenge in small cell transformation after EGFR-TKI failure: a case report
    Lee, Sanghun
    Joo, Jeonghyun
    Kwak, Minah
    Sohn, Kicheul
    Chon, Songha
    ONCOTARGETS AND THERAPY, 2018, 11 : 3943 - 3947
  • [8] SYNERGISTIC EFFECT OF HISTONE DEACETYLASE INHIBITOR IN COMBINATION WITH EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR IN EGFR-TKI RESISTANT NON-SMALL CELL LUNG CANCER CELL LINES
    Han, X.
    Zhang, N.
    Yao, J.
    Shi, Y.
    ANNALS OF ONCOLOGY, 2015, 26
  • [9] Efficacy and safety of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) monotherapy for advanced EGFR-mutated non-small cell lung cancer: systematic review and meta-analysis
    Lee, H. J.
    Jeong, G. H.
    Li, H.
    Kim, M. S.
    Kim, J. S.
    Park, S. J.
    Han, Y. J.
    Lee, K. H.
    Kronbichler, A.
    Hong, S. H.
    Ghayda, R. A.
    Luchini, C.
    Nottegar, A.
    Koyanagi, A.
    Smith, L.
    Jacob, L.
    Dragioti, E.
    Radua, J.
    Cargnin, S.
    Terrazzino, S.
    Thompson, T.
    Yon, D. K.
    Lee, S. W.
    Yang, J. M.
    Wasuwanich, P.
    Shin, J. I.
    Gamerith, G.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (20) : 6232 - 6244
  • [10] Clinical Significance of Sequential Treatment with Afatinib in the Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Treatment of Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)
    Kobayashi, N.
    Aiko, H.
    Kamimaki, C.
    Mikami, N.
    Kubo, S.
    Tei, Y.
    Hirama, N.
    Katakura, S.
    Teranishi, S.
    Manabe, S.
    Yamamoto, M.
    Kudo, M.
    Kaneko, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
12345